RT Conference Proceedings
T1 Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008
A1 Eigentler, T.
A1 Heinzerling, L.
A1 Krauss, J.
A1 Weishaupt, C.
A1 Ochsenreither, S.
A1 Lebbe, C.
A1 Mohr, P.
A1 Oliva, M.
A1 Oberoi, H. K.
A1 Terheyden, P.
A1 Perez, J. M. Trigo
A1 Robert, C.
A1 Bauernfeind, F-G.
A1 Fluck, M.
A1 Richtig, E.
A1 Soria, A.
A1 Kays, S-K.
A1 Schmitt-Bormann, B.
A1 Falk, M.
A1 Gnad-Vogt, U. S.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/27062
UL https://hdl.handle.net/10668/27062
LA en
DS RISalud
RD Apr 8, 2025